Sublimation Byk: Development of 20% tryptophan premix new phenylalanine

2012 Annual Report - Sublimation Byk: Development of 20% tryptophan premix New phenylalanineSiF2012 Company's operating income of 1.652 billion yuan, down 6.44% YoY;SiF
The company's main business products market demand is weak, product prices continue to fall, the price of the fourth quarter has fallen rapidly, resulting in a sharp decline in the operating income of the products compared with the same period last year;SiF
Although amino acids are not the company's main products, but the company still holds the concept of strengthening technological innovation, in 2012, successfully developed 20% L-tryptophan premix new process new dosage form, in addition to speeding up the new product L-phenylalanine industrializationFor the 10% tryptophan premix and 500 tons of high-purity tryptophan project, which has an annual output of 200,000 tons, it has not yet been fully completed and is partially put into useSiF
The Company expects 2013 revenue of RMB1.700 billion and total operating costs planned to be RMB1.670 billionIn 2013, the main focus is on the main industry, continue to do a great advantage of products, especially the advantages of veterinary drugs; Further improve the market share of major products such as sulfur viscose, tryptophan, saline, moone premix, methyl-dimensional salt, wheat grass, diglyceium, oxychloride, acetylacetone and other major products;SiF2012 Annual Report - Sublimation Byk: Developmentof 20% tryptophan premix New phenylalanine2012 Company operating income of 1.652 billion yuan, down 6.44% YoY;SiF
The company's main business products market demand is weak, product prices continue to fall, the price of the fourth quarter has fallen rapidly, resulting in a sharp decline in the operating income of the products compared with the same period last year; SiF
Although amino acids are not the company's main products, but the company still holds the concept of strengthening technological innovation, in 2012, successfully developed 20% L-tryptophan premix new process new dosage form, in addition to speeding up the new product L-phenylalanine industrialization For the 10% tryptophan premix and 500 tons of high-purity tryptophan project, which has an annual output of 200,000 tons, it has not yet been fully completed and is partially put into use SiF
The Company expects 2013 revenue of RMB1.700 billion and total operating costs planned to be RMB1.670 billion In 2013, the main focus is on the main industry, continue to do a great advantage of products, especially the advantages of veterinary drugs; Further improve the market share of major products such as sulfur viscose, tryptophan, saline, moone premix, methyl-dimensional salt, wheat grass, diglyceium, oxychloride, acetylacetone and other major products; SiF